NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of providing high-quality chemical compounds that drive progress in the pharmaceutical industry. Among these essential compounds is Ritalinic acid, identified by its CAS number 19395-41-6. This molecule plays a critical role as a pharmaceutical intermediate, particularly in the development of medications for Attention Deficit Hyperactivity Disorder (ADHD). Its ability to modulate neurotransmitter activity makes it invaluable for enhancing focus and cognitive function in patients seeking treatment for ADHD.

The importance of Ritalinic acid extends beyond its direct application in ADHD medications. Its unique chemical structure also makes it a valuable asset in various fields of scientific research. In neuroscience, Ritalinic acid is employed to study the complex mechanisms of neurotransmitter systems and to gain deeper insights into behavioral disorders. This research is crucial for developing new therapeutic strategies and understanding the underlying causes of neurological conditions.

Furthermore, Ritalinic acid finds application in analytical chemistry. It is used in the development of sophisticated analytical methods for detecting and quantifying stimulant drugs in biological samples. This capability is vital for forensic analysis, drug testing, and clinical diagnostics, ensuring accuracy and reliability in identifying substances.

The field of formulation science also benefits significantly from Ritalinic acid. Its properties are leveraged in the creation of advanced drug delivery systems, particularly those designed for controlled release. Such formulations aim to optimize the efficacy of medications, improve patient compliance, and minimize potential side effects by ensuring a steady and predictable release of the active compound over time.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting these diverse applications by ensuring a consistent supply of high-purity Ritalinic acid. Our dedication to quality and innovation empowers researchers and pharmaceutical manufacturers to push the boundaries of medical science. By providing access to critical intermediates like Ritalinic acid, we contribute to the development of more effective treatments and a better understanding of human health.